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Mechanical ventilation is a lifesaving therapy in patients who have acute  
respiratory failure due to chronic obstructive pulmonary disease (COPD). 
Mechanical ventilaton either invasive or non-invasive has an important role in the 
management of acute exacerbation of COPD (AECOPD). AECOPD required hos-
pitalizaton had increased mortality and poor prognosis. Ventilatory management 
success related to understanding physiopathology of the disease. Clinicians must 
be aware of deterioration of clinical signs of COPD patients. The most appropriate 
treatment should be performed at optimal time. Some COPD patients are at high 
risk for prolonged mechanical ventilation due to COPD is a progressive disease.
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1. Introduction
Chronic obstructive pulmonary disease (COPD) is a major global health problem 
which has high morbidity and mortality [1]. COPD is characterized by chronic 
inflammation of the airways and lung parenchyma. The most important physiologic 
abnormality is worsening of expiratory airflow limitation due to increased airway 
resistance and decreased elastic recoil [2]. Patients who have fexpiratory airflow 
limitation cannot breath normally and due to dynamic hyperinflation increase work 
of breathing. These physiologic changes are deteriorated unless avoid risk factors 
because of COPD is a progressive disease and can be complicated with different 
severity of acute exacerbation [1–4].
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is 
described an acute worsening of the clinical condition of the COPD patient [5]. 
Clinical features are highly variable and AECOPD has a negative impact of patients’ 
health status and outcomes [1, 6–8]. The reported mortality associated with a 
AECOPD is variably at 11% to 32% [9]. The mortality rate and costs are much higher 
in some patients requiring mechanical ventilation [10, 11]. In severe AECOPD, it is 
crucial to recognise acute respiratory failure (ARF) immediately and to decide appro-
priate treatment. ARF is defined as the inability to maintain the delivery of oxygen 
and/or removal of carbon dioxide acutely. Worsening gas exchange and consequently 
hypercapnia and/or hypoxemia occur in arterial blood gas sample (ABG) analysis [12].
2. Non-invasive ventilation
Mechanical ventilation either invasive or non- invasive is lifesaving treatment 
for acute respiratory failure. It is targeted by non - invasive ventilation (NIV) 
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to minimize risks of mechanical ventilation and maximize patients’ safety 
and comfort. Hence NIV is successful to provide alveolar ventilation and gas 
exchange as invasive mechanical ventilation (IMV); NIV accepted widely as the 
first choice in treating AECOPD patients with ARF [13–24]. NIV therapy suc-
cess is related to appropriate patient selection and early application [14, 25–27]. 
The appropriate patient means that is alert, co-operative, compliant and has no 
contraindications [28].
NIV is applied after initial treatment if the pH remains <7.30 and after exclusion 
of reversible precipitating causes such as a pneumothorax, the depressant effect of 
uncontrolled oxygen therapy, or the excessive use of sedatives [29–31]. According to 
GOLD guide, NIV is considered at least one of these conditions; respiratory acido-
sis, weakness of respiratory muscles, severe dyspnea, increased work of breathing, 
accessory muscle using, intercostal retraction, paradoxal breathing and persistant 
hypoxemia with oxygen therapy [32]. Main determinants are experience of the 
clinician, place of the NIV therapy, clinical condition and theurapeutic requirement 
of patient [33, 34].
NIV can be apply with all ventilators used in IMV support [35]. It’s important to 
known technical specialities and settings by clinician. Portable ventilators, inter-
mediate ventilators and ICU ventilators has been used [33, 36]. Portable ventilators 
are named according to targeted parameter as volume and pressure ventilators. The 
synonim name is portable device is bilevel or BiPAP (Bilevel positive airway pres-
sure) ventilator. Clinicians must be aware of difference between settings of the two 
devices: While adjusting IPAP (inspiratory positive airway pressure), EPAP (expi-
ratory positive airway pressure) levels setting in BiPAP device, pressure support 
(PS = IPAP - EPAP) and EPAP levels in ICU ventilators [33, 37]. Bi-level pressure 
support ventilators are simpler to use, cheaper, and more flexible than other 
types of ventilator currently available. ICU ventilators have full monitoring and 
alarm capability and can be given up to 100% FiO2 when needed [30, 33]. Whole 
appropriate equipment must be ready to iniciate the NIV therapy as single/double 
lumen circuit, nasal/oronasal NIV mask by different size [38]. Mask selection is 
more important than ventilator. In acute setting, oronasal mask is well tolerated and 
preferred by many clinicians [14, 38, 39].
NIV is contraindicated in these situations; respiratory or cardiac arrest, hemo-
dynamic instability, inability to use mask, excessive secretion, high risk for aspira-
tion, and uncooperative patient.
Initially it is began with low pressure levels as IPAP 8–10 cm H2O and EPAP 
4–5 cm H2O. According to patient’s clinical status, pressure levels can be increased. 
Monitorization of clinical signs, parameters of mechanical ventilation and gas 
exchange at the bedside are very important. Especially clinician must be follow 
and record subjective symptoms like anxiety, consciousness, delirium, agitation, 
sedation, analgesia, patient comfort, dyspnea, tolerance of mask. All the time NIV 
therapy, physiological response like respiratory rate (RR), using accessory muscle, 
heart rate (HR) and rhythm, blood pressure (BP) must be recorded. After the first 
1–2 hours ABG must be done. We must consider intubation, if no improvement in 
ABG, deterioration in level of consciousness, NIV poorly tolerated, and inadequate 
secretion clearance [1, 7, 21, 40].
NIV failure is associated with hospital mortality, length of hospital and ICU 
stay [41]. NIV failure indicators are found as initial pH <7.25, Glascow Coma 
Scale (GCS) <10, Acute Physiology and Chronic Health Evaluation (APACHE) II 
score > 25, severe comorbidity, asynchrony, leaks [7, 42], existing pneumonia, and 
bad initial response (no change RR, pH and paCO2) [14, 43]. The potantial causes 
NIV failure are defined that poor patient selection, progression of the underly-
ing disease, wrong interface, wrong ventilator, inappropriate ventilator settings 
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and clinican’s inexperience [44]. In a study, HACOR scores (heart rate, acidosis, 
consciousness, oxygenation, respiratory rate) be defined as a potential tool for 
clinical physicians to identify NIV failure earlier [45]. Patient tolerance to NIV is 
a critical factor determining its success in avoiding endotracheal intubation [46]. 
The most important point of the tolerance to NIV is optimal synchrony between the 
patient’s spontaneous breathing activity and the ventilator’s set parameters, known 
as “patient–ventilator interaction” [47]. Clinician can detected an asynchrony 
index (AI) (%) via visual inspection of asynchrony events (ineffective triggering, 
auto-triggering, premature cycling, double triggering and delayed cycling). AI is 
identified as number of asynchrony events/total RR X 100% and above 10% was 
accepted as severe asynchrony [44]. In a multicenter study, severe asynchrony was 
found 43% [48]. The level of pressure support and the existing of leaks were found 
independent predictive factors of severe asynchronies and severe asynchronies were 
detected 30% of patients [49]. Patient-ventilator synchrony is related to better suc-
cess of NIV. For this reason, in case of asynchrony, the most appropriate strategies 
should be followed to improve synchronization with NIV [44].
3. Invasive mechanical ventilation
Endotracheal intubation should be done any one of the following criteria 
immediately: respiratory arrest, loss of consciousness, psychomotor agitation 
requiring sedation, hemodynamic instability with a systolic BP less than 70 or 
greater than 180 mmHg, HR less than 50 beats/minute with loss of alertness, 
gasping for air. These criteria are named major criteria. Intubation was suggested 
any two of the following criteria also named minor criteria; RR >35 breath/min, 
worsening acidemia or pH < 7.25, paO2 < 40 mmHg or paO2/FiO2 < 200 despite 
oxygen therapy, decreasing level of consciousness [50]. Before intubation pre-
oxygenation is essential. Intubation with the rapid sequence induction and cricoid 
pressure to reduce the risk of aspiration should ideally be performed by an  
experienced clinician [51].
After intubation, its targeted to improve gas exchange abnormality and to avoid 
auto-PEEP (PEEPi) [7, 52]. Dynamic hyperinflation(DHI) may exist before intuba-
tion or induced by mechanical ventilation. The minute volume (MV) should be 
adjusted to pH and not to the PaCO2 levels. Clinicians should be avoid overventila-
tion and paCO2 levels should decreased gradually. It is important to provide lower 
MV (RR x tidal volume (TV)) and higher inspiratory flow rate which has allow 
longer expiratory time. Any mode can be used, either assist control (AC), synchro-
nized intermittent mandatory ventilation with either volume or pressure target 
(SIMV-VS, SIMV-PS), or pressure support ventilation(PSV). Clinician’s experience 
is the most important determinant of mode selection. Initial ventilator settings are 
recommended like that; TV: 6–10 ml/kg, FiO2: 1.0, RR: 10–14 breaths/minute, no 
PEEP, inspiratory flow rate: 80–100 liter/minute with square waveform [1, 2, 4]. 
Monitoring the lung mechanics on ventilator graphic screen continously and detect-
ing any sign of DHI or PEEPi are very important. The clinicians should be followed 
existing any clinical signs to avoid the complications of DHI. The most important 
complications of DHI are hypotension, hemodynamic collaps, barotrauma and 
increased work of breathing (WOB) [51, 53]. Therefore, that strategies must be 
applied by clinicians to reduce auto-PEEP; providing the longest expiratory phase 
that is possible, reducing patient ventilatory demand and MV, and reducing airflow 
resistance by bronchodilators and steroids [1].
Barotrauma is an important risk at the COPD patients. Elevated peak inspiratory 
pressure (PIP) does not reflect the alveolar pressure in patients with bronchospasm. 
Chronic Obstructive Pulmonary Disease - A Current Conspectus
4
Alveolar pressure can be detected with plateau pressure (Pplat) and suggested 
PIP < 50 cmH2O, Pplat < 30 cmH2O to avoid barotrauma [1].
Quantifying PEEPi is a difficult and favored process. PEEPi amount of propor-
tionated with degree of bronchial obstruction. Different techniques can be used to 
calculate PEEPi. Clinicians can directly measure by occluding the expiratory port 
for 1–3 seconds at end expiration or by using expiratory hold maneuver on new 
ventilators. Static PEEPi can be measured in this way only in sedatized patients 
without active respiratory effort. The PEEPi can then be calculated by subtract-
ing the external PEEP from the total PEEP. If there is spontan respiratory effort 
of the patient, dynamic PEEPi can be determined by simultanously recording 
esophageal pressure and airflow tracings. It is measured at end expiration as the 
negative deflection of esophageal pressure to the point of zero flow. The dynamic 
PEEPi is usually measured lower than static PEEPi by reason of different longer of 
time constant [1, 2, 4, 53, 54]. While PEEPi is determined extrinsic PEEP (PEEPe) 
at 80% of PEEPi should be added to reduce patient triggering effort. Ventilator 
trigger sensitivity must be justify minimal [1, 4, 6, 51, 55, 56].
Weaning should begin once the cause of the exacerbation is adequately treated 
and the patient is hemodynamically stable. Physiologic parameters must be fol-
lowed intensively. It’s targeted MV < 15 L, RR < 30 breaths/minute, TV > 325 ml, 
rapid shallow breathing index (RSBI) <105, maximum inspiratory pressure 
(MIP) < −15. Although the superiority did not found among each other, different 
strategies were used to weaning. Daily spontaneous breathing trail (SBT) is one 
way of identifying patients stable to wean and it may reduce the number of ICU 
days. While decreasing gradually of PS has not been shown to be superior to SBT, 
PSV is preferable by many clinicians. Using NIV to facilitate weaning is accepted by 
multiple RCT [14, 15, 52, 57, 58].
4. High flow oxygen therapy
Long term oxygen therapy (LTOT), is used mainly in COPD patients with 
chronic hypoxemia [32]. High flow oxygen therapy (HFOT) is a new technique for 
delivering oxygen. There are many studies using HFOT instead of conventional 
oxygen therapy (COT) recently. HFOT was well tolerated and was sensed as 
comfortable. By using this system, oxygen delivery trends provided to be lower, and 
paCO2 levels could be measured significant decreased. HFOT could be accepted 
as an alternative treatment to NIV due to it generates a modest degree of positive 
pressure almost 5–6 cmH2O. It provides a more physiological humidification and 
heating of the airways. In this settings, HFOT has been used with different aims, as 
an alternative to COT, and NIV [59–62].
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